Researchers stop cell suicide that worsens sepsis, arthritis

August 24, 2018, Case Western Reserve University
Credit: CC0 Public Domain

Researchers from Case Western Reserve University School of Medicine have discovered a way to stop immune cell death associated with multiple diseases, including sepsis, inflammatory bowel disease (IBD), and arthritis.

The findings, published in Science Immunology, identify a chemical that potently inhibits inflammatory cell death. Cells often perforate their own membranes in response to extreme inflammation—a type of cell suicide known as pyroptosis. In human cells and animal models, the chemical prevents these deadly holes from forming inside cell membranes. This is a new pharmacologic approach to stopping this destructive process.

"To date, there has been no pharmacologic mechanism to directly inhibit pyroptotic ," said Derek Abbott, MD, Ph.D., Arline H. and Curtis F. Garvin Professor of Medicine at Case Western Reserve School of Medicine and member of the Case Comprehensive Cancer Center, whose lab performed the work. "We knew necrosulfonamide inhibited another type of pore formation and had a hunch it might work against pyroptosis, too. We found necrosulfonamide is effective in our sepsis models, and could be effective to treat diseases worsened by inflammation."

In the new study, mice treated with the chemical necrosulfonamide survived longer than untreated mice, after exposure to bacterial proteins that cause inflammation. The results suggest the chemical alleviates extreme, harmful inflammation associated with bacterial sepsis. Necrosulfonamide has never before been studied as a pharmacologic agent.

Pyroptosis is part of a vicious cycle in many diseases. As dying cells poke holes in their membranes, they leak molecules that recruit more immune cells. The sudden influx of new cells also initiates cell death, and another round of pyroptosis occurs. Chronic inflammation can result, including the type that underlies arthritis and IBD. Abbott, who is also a professor of pathology and Co-Director of the Medical Scientist Training Program (MSTP) at Case Western Reserve School of Medicine, and his team sought a way to stop pyroptosis while preserving other necessary immune cell functions.

The researchers tested necrosulfonamide by adding it to growing in their laboratory. Even in the face of inflammatory triggers, like bacteria, exposed to the chemical remained intact. They did not leak dyes or other molecules, and still sent signals to other cells as part of normal, healthy function.

The new study also describes how necrosulfonamide works inside . Abbott's team used biochemical analyses to show it directly attaches to gasdermin D—a protein that destroys cell membranes. During pyroptosis, long chains of gasdermin D aggregate inside cell membranes, forming pores. Necrosulfonamide physically gets in the way of this process. With the large chemical attached to it, gasdermin D can't aggregate.

The researchers studied different gasdermin D variations to pinpoint the exact location where necrosulfonamide attaches. They found it attaches to regions where gasdermin D proteins connect to each other. The specific attachment mechanism differs from how the inhibits enzymes involved in other types of .

"Our results suggest gasdermin D inhibitors are clinically possible," said Joseph Rathkey, first author on the study and student in the MSTP at Case Western Reserve School of Medicine. "We've provided proof of principle that destructive pore formation can be inhibited, and that gasdermin D is a viable pharmaceutical target." He says the "high therapeutic potential" of chemicals like necrosulfonamide could inform future studies in humans.

Explore further: How do cells release IL-1? After three decades, now we know

More information: Joseph K. Rathkey et al, Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis, Science Immunology (2018). DOI: 10.1126/sciimmunol.aat2738

Related Stories

How do cells release IL-1? After three decades, now we know

November 28, 2017
Researchers at Boston Children's Hospital have identified, for the first time, the molecule that enables immune cells to release interleukin-1 (IL-1), a key part of our innate immune response to infections. Findings were ...

Cell death: How a protein drives immune cells to suicide

July 14, 2016
For some pathogens, attack is the best form of defense—they enter immune cells of the human body. However, if they are detected in their hidden niche, the infected cell kills itself to re-expose the pathogens. In the EMBO ...

A new angle for countering severe bacterial infections and sepsis

July 6, 2016
Bacterial infections that don't respond to antibiotics are of rising concern, as is sepsis—the immune system's last-ditch, failed attack on infection that ends up being lethal itself. Reporting online in Nature on July ...

Guardians of the Ring—Researchers reveal structure of protein involved in inflammatory diseases

May 2, 2018
When the body detects a threat, be it a viral invader or an Alzheimer's disease plaque, guardian proteins on the cell surface kick into gear.

Savior of T-cells may be enemy of liver immune cells

April 24, 2017
Researchers at Houston Methodist demonstrated that a surface protein called OX40, responsible for keeping one type of immune system cell alive, can trigger the death of liver immune cells, in turn starting a chain reaction ...

Discovery shines light on the mystery of cell death in multiple sclerosis

June 12, 2018
Researchers at the University of Alberta have discovered a unique process of brain cell death that affects the cells that are most vulnerable in multiple sclerosis (MS).

Recommended for you

Gut fungus exacerbates asthma in antibiotic-treated mice

September 20, 2018
A non-pathogenic fungus can expand in the intestines of antibiotic-treated mice and enhance the severity of allergic airways disease, according to a study published September 20 in the open-access journal PLOS Pathogens by ...

Paracetamol use in infancy is linked to increased risk of asthma in some teenagers

September 17, 2018
Children who take paracetamol during their first two years of life may be at a higher risk of developing asthma by the age of 18, especially if they have a particular genetic makeup, according to new research presented at ...

Cord blood clue to respiratory diseases

September 15, 2018
New research has found children born in the last three months of the year in Melbourne may have a greater risk of developing respiratory diseases such as asthma.

FRESH program combines basic science with social benefits for women at risk of HIV

September 14, 2018
A program established by investigators from the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard is addressing the persistently elevated risk of HIV infection among young women in South Africa from ...

Dietary fiber reduces brain inflammation during aging

September 14, 2018
As mammals age, immune cells in the brain known as microglia become chronically inflamed. In this state, they produce chemicals known to impair cognitive and motor function. That's one explanation for why memory fades and ...

Research reveals link between immunity, diabetes

September 14, 2018
When it comes to diet-induced obesity, your immune system is not always your friend.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.